U.S. Luxury Stock News

In May 2026, Dana Incorporated reported past first-quarter 2026 results showing sales of US$1,868 million versus US$1,781 million a year earlier, with net income rising to US$1.09 billion from US$25 million, while still recording a basic loss per share of US$0.17 from continuing operations. The contrast between the very large net income and the loss per share from continuing operations suggests that one-off or non-core items played a major role in shaping overall profitability. We’ll now...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

It looks like Evercore Inc. ( NYSE:EVR ) is about to go ex-dividend in the next 4 days. The ex-dividend date is usually...

It looks like AngloGold Ashanti plc ( NYSE:AU ) is about to go ex-dividend in the next four days. The ex-dividend date...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see JAKKS...

It's been a pretty great week for Ralph Lauren Corporation ( NYSE:RL ) shareholders, with its shares surging 16% to...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Maase (MAAS) has drawn fresh attention after a sharp recent move in its stock, prompting investors to look more closely at this China focused financial services and technology platform listed on the Nasdaq. See our latest analysis for Maase. The recent surge in Maase’s share price, including a 9.22% 1 day share price return and 103.43% year to date share price return, points to strengthening momentum as investors reassess its China focused financial technology platform. If Maase’s move has...

Mativ Holdings, Inc. ( NYSE:MATV ) stock is about to trade ex-dividend in four days. Typically, the ex-dividend date is...

Why MYR Group (MYRG) Is On Investors’ Radar Now MYR Group (MYRG) is back in focus after reporting robust earnings per share growth, stronger free cash flow margins, and recent share repurchases that collectively point to a more efficient use of capital. See our latest analysis for MYR Group. The recent earnings strength sits alongside a sharp move in the stock, with a 30-day share price return of 31.72% and a 90-day share price return of 62.82%. The 1-year total shareholder return of 183.91%...

Union Pacific Corporation ( NYSE:UNP ) is about to trade ex-dividend in the next four days. The ex-dividend date occurs...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Readers hoping to buy T-Mobile US, Inc. ( NASDAQ:TMUS ) for its dividend will need to make their move shortly, as the...

Despite the fact that Chaince Digital Holdings Inc.'s (NASDAQ:CD) value has dropped 11% in the last week insiders who...

Ross Stores, Inc. ( NASDAQ:ROST ) just released its quarterly report and things are looking bullish. Ross Stores beat...

LuxExperience B.V (LUXE) drew fresh attention after reporting third quarter and nine month results that paired higher sales with a wider net loss, while also closing the sale of THE OUTNET and outlining a YNAP transformation plan. See our latest analysis for LuxExperience B.V. The latest quarter, with higher sales but a wider loss and fresh restructuring charges, has coincided with pressure on the stock, which is down 21.31% on a 1 month share price basis and 22.53% on a 1 year total...

Earlier in May 2026, VEON Ltd. reported first-quarter 2026 results showing revenue of US$1,201 million versus US$1,026 million a year earlier, with net income steady at US$99 million and basic and diluted earnings per share from continuing operations unchanged at US$1.5. Alongside raising its 2026 revenue growth guidance, launching a US$100 million share buyback, and issuing US$1.4 billion of new bonds to refinance existing debt, VEON highlighted rapidly expanding digital revenues and...

Earlier in May 2026, Nvidia invested US$10.40 million in Generate Biomedicines, an AI-driven biotech now advancing several drug candidates through clinical development, including a Phase 3 severe asthma program and oncology therapies with FDA Fast Track status. This combination of external validation from a major AI leader and visible clinical momentum underscores how AI-enabled drug discovery is moving from concept toward real-world testing. Next, we’ll examine how Nvidia’s investment and...

Bullish recently reported first-quarter 2026 results showing US$20.01 million in sales and a net loss of US$581.71 million, while also announcing a US$4.20 billion acquisition of Equiniti and facing widening per-share losses versus a year earlier. Amid these developments and broader digital asset volatility, ARK Invest and other institutional investors have been actively building positions in Bullish, signaling renewed institutional focus on its role in tokenization and crypto-market...

Ambiq Micro stock: quick context on recent performance Ambiq Micro (AMBQ) has been drawing attention after sharp recent gains, with the stock up 130% over the past month and up about 172% over the past 3 months. That move comes as investors weigh a US$1.75b market value against the company’s US$81.8m in revenue and a reported net loss of US$38.3m from its ultra low power semiconductor business. See our latest analysis for Ambiq Micro. At a share price of US$81.67, Ambiq Micro’s recent surge,...

Earlier this week, Columbia Sportswear’s shares reacted to easing Treasury yields and progress in Iran peace talks, as lower rate expectations and reduced inflation concerns supported companies tied to discretionary consumer spending. Valuation metrics now suggest a sizeable margin of safety alongside a strong overall GF Score™, even as insider activity has been limited to modest selling in recent months. We’ll now examine how cooling Treasury yields and the market’s renewed risk appetite...

Earlier this month, UL Solutions Inc. announced a quarterly dividend of US$0.145 per share payable on June 8, 2026, while also reporting strong first-quarter 2026 results and unveiling AI-powered ULTRUS UL 360 software for product carbon footprint and Scope 3 emissions data management. Alongside reinforcing its role in safety with a public warning about electric scooters bearing unauthorized UL Marks, the company is extending its reach into digital sustainability tools that help customers...

Earlier in May 2026, Xenon Pharmaceuticals reported stronger-than-expected Q1 results, with its X-TOLE2 study of azetukalner in focal onset seizures exceeding internal expectations and supporting plans to submit a New Drug Application to the FDA in Q3 2026. This progress underscores how clinical momentum in azetukalner, supported by extensive trial data, is increasingly central to Xenon’s broader neuroscience ambitions. Next, we’ll explore how Xenon’s X-TOLE2 outperformance and upcoming FDA...